Hye Won Hwang

Hye Won Hwang

Auto-generated profile, based on publicly available information

Hye Won Hwang

Department of Dermatology, Inha University School of Medicine, Incheon, Korea

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 January 2012 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
BPByeong-Woo Park
Byeong-Woo Park
SPSeho Park
Seho Park
HPHyung Seok Park
Hyung Seok Park
Ja Seung KooJa Seung Koo
Ja Seung Koo
WYWoo Ick Yang
Woo Ick Yang
KLKyong Sik Lee
Kyong Sik Lee

1 January 2024 in Annals of Dermatology
Verified
Journal Article
Open access
PDF file
HHHye Won Hwang
Hye Won Hwang
SRSunmin Ryou
Sunmin Ryou
JJJun Hyeong Jeong
Jun Hyeong Jeong
JLJae Won Lee
Jae Won Lee
KLKyung-Ju Lee
Kyung-Ju Lee
GCGwang Seong Choi
Gwang Seong Choi
Hwang HW, et al. Ann Dermatol. 2024 Feb;36(1):44-52. https://doi.org/10.5021/ad.23.082

1 January 2024 in Annals of Dermatology
Verified
Journal Article
Open access
PDF file
SLSeon Bok Lee
Seon Bok Lee
JLJae Won Lee
Jae Won Lee
HLHyemin Lee
Hyemin Lee
KLKyung-Ju Lee
Kyung-Ju Lee
HHHye Won Hwang
Hye Won Hwang
GCGwang Seong Choi
Gwang Seong Choi
Lee SB, et al. Ann Dermatol. 2024 May;36:e40. https://doi.org/10.5021/ad.23.128

13 May 2024 in International Journal of Cancer
Verified
Journal Article
Open access
HHHye Won Hwang
Hye Won Hwang
HSHyun-Tae Shin
Hyun-Tae Shin
HAHye Young An
Hye Young An
JBJi Won Byun
Ji Won Byun
Cutaneous squamous cell carcinoma (cSCC) is the second most common skin cancer. While many treatments exist, our understanding of its genomic progression, especially from the epidermis to the deep dermis, remains limited. This study aims to identify genetic mutations associated with the progression of cSCC into the deep dermis, providing insights into its aggressive behavior and high‐risk features. We performed high‐depth whole‐exome sequencing on 12 cSCC tissues, along with paired normal tissues from six patients, using microdissection techniques. The mutational analysis focused on identifying alterations enriched during cSCC progression. Gene Ontology enrichment analysis, immunohistochemical assays, and external single‐cell RNA data were utilized for validation. A total of 8863 non‐synonymous somatic mutations were identified in 4092 genes across the superficial and deep portions of cSCCs. Analysis of deep portion mutations revealed a significant correlation with gene ontology biological processes, particularly cell junction organization, and cell–cell adhesion. Clonal mutations in these processes were more prevalent in the deep portions, indicating their impact on the cSCC mutation landscape. Genetic evolution analysis identified 29 causal genes associated with dermal invasion in cSCC. We highlight somatic mutations in cSCC, revealing heterogeneity between superficial and deep regions. Altered genes in cell junction organization and cell–cell adhesion emerged as pivotal in dermal invasion. We identified 29 causal genes primarily in deep tumor regions. Our findings emphasize analyzing multiple tumor regions to capture varied mutational landscapes. These insights advance our understanding of cSCC progression, emphasizing genetic and cellular changes during tumor evolution.

1 January 2023 in Annals of Dermatology
Verified
Journal Article
Open access
PDF file
HHHye Won Hwang
Hye Won Hwang
SLSeon Bok Lee
Seon Bok Lee
JSJeonghyun Shin
Jeonghyun Shin
GCGwang Seong Choi
Gwang Seong Choi
JBJi Won Byun
Ji Won Byun
Hwang HW, et al. Ann Dermatol. 2023 May;35:e51. https://doi.org/10.5021/ad.21.183

25 June 2026 in Journal of Cosmetic and Laser Therapy
Verified
Journal Article
Closed access
HHHye Won Hwang
Hye Won Hwang
JLJae Won Lee
Jae Won Lee
JJJun Hyeong Jeong
Jun Hyeong Jeong
KLKyung-Ju Lee
Kyung-Ju Lee
HSHyun-Tae Shin
Hyun-Tae Shin
JSJeonghyun Shin
Jeonghyun Shin
Neurogenic rosacea (NR) poses a therapeutic challenge due to its resistance to conventional treatments. This study explores the efficacy of pulsed-dye laser (PDL) therapy in managing NR. We present two cases of NR with severe facial discomfort and photoaging, treated with PDL alongside oral medications. Remarkably, PDL significantly alleviated pain and improved skin appearance in both cases, with sustained relief for over 2 years. Mechanistically, PDL may modulate neuropeptides and nerve fiber density implicated in NR pathogenesis. Our findings suggest PDL as a promising therapeutic avenue for NR, warranting further investigation and consideration in clinical practice.